Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Alzheimer's disease is at the center of a revolutionary theory in neuroscience, where the mysteries of the human brain ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

A new study has found that taking longer to reach the rapid eye movement (REM) stage of sleep is linked to a greater risk of ...

When younger people reach a stage that requires extra care, this may create the impression that the disease has moved faster. However, it’s not clear whether or not early onset Alzheimer’s ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms ...

Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.

The sabotage of cellular messaging, triggered by the formation of chronic stress granules in the brain, may be a key factor ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Scientists Identify Alzheimer's Disease-Protective Genetic ... candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the ...